- Hoffmann-La Roche of Switzerland affiliates Roche Taishan Vitamin Products Company and Roche Sanwei Vitamin Company, the largest production facility for vitamin A and vitamin E, held a ground-breaking ceremony in Pudong, Shanghai. The two companies jointly invested $47 million in this project, the total sales revenues of which are expected to reach $150 million.
Until now, Roche has established five joint ventures in Shanghai, with the total investment at more than $100 million, reports China Medipharm Insight, and thus becomes the biggest foreign partner of Shanghai city.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze